David J Mauro
CIK 1621172 · Chief Medical Officer · last filed 2024-11-19
David J Mauro is a Chief Medical Officer who has filed 37 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider had shares withheld for taxes covering $25.9K of RXRX on Nov 19, 2024. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $750.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$750.9K
4
37
-$5.86M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RXRX | Chief Medical Officer | 225,429 | $3.15 | $710.1K | $0 | 5 | 2024-11-19 |
| Codiak BioSciences, Inc. (CDAK) Delisted | Chief Medical Officer | — | $0.06 | — | $0 | 3 | 2023-01-26 |
| PRLD | Chief Medical Officer | 9,092 | $4.49 | $40.8K | -$5.61M | 11 | 2021-10-06 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Medical Officer | 166,271 | — | — | -$247.8K | 18 | 2016-01-04 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-19 | RXRX | Tax (F) | −4,187 | -$25.9K | EDGAR |
| 2024-08-19 | RXRX | Tax (F) | −14,146 | -$94.6K | EDGAR |
| 2024-05-17 | RXRX | Tax (F) | −867 | -$8.7K | EDGAR |
| 2024-02-13 | RXRX | Mixed | +53,916 | -$19.1K | EDGAR |
| 2023-06-07 | RXRX | Grant (A) | +190,713 | $0 | EDGAR |
| 2023-01-26 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-20 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-04 | Codiak BioSciences, Inc. (CDAK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-06 | PRLD | Mixed | — | -$436.0K | EDGAR |
| 2021-09-09 | PRLD | Mixed | — | -$521.9K | EDGAR |